Skip to content

Drug interactions

Deferiprone + Mitomycin

Severity: Major

Deferiprone and Mitomycin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mitomycin is a myelosuppressive cytotoxic that can cause delayed and cumulative bone marrow suppression. Combined with deferiprone, the risk of severe neutropenia and agranulocytosis is increased.

What this interaction means in plain words

Deferiprone and Mitomycin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Deferiprone belongs to Miscellaneous; Mitomycin belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive myelosuppression affecting neutrophil production.

What to do

Avoid combined use if alternatives exist; otherwise monitor absolute neutrophil count more frequently and withhold deferiprone if neutropenia develops.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Mitomycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Deferiprone with Mitomycin?

MediHelp rates the interaction as major. Deferiprone and Mitomycin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mitomycin is a myelosuppressive cytotoxic that can cause delayed and cumulative bone marrow suppression. Combined with deferiprone, the risk of severe neutropenia and agranulocytosis is increased.

How serious is the interaction between Deferiprone and Mitomycin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combined use if alternatives exist; otherwise monitor absolute neutrophil count more frequently and withhold deferiprone if neutropenia develops.

What other medicines interact with Deferiprone?

MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in